Navigation Links
NIH awards more than $33 million to fund state-of-the-art research equipment

The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today that it will provide $33.3 million for 20 High-End Instrumentation (HEI) grants to fund the latest generation of advanced research equipment. Awarded to research institutions nationwide, these one-time grants, which support the purchase of sophisticated research equipment costing more than $750,000, offer extraordinary potential to impact a wide variety of biomedical research in many disease areas.

"Innovative biomedical research requires frequent access to the newest and most advanced technology," said NCRR Director Barbara Alving, M.D. "High-performance equipment provides NIH-funded researchers with new discovery tools enabling a new generation of data and a new dimension of information. Tools such as these play key roles in the study of disease and the fundamental mechanisms of biological function, ultimately leading to new advances and treatments for diseases."

High-End Instrumentation awards enable the purchase of breakthrough new technologies and one-of-a-kind research tools, opening up new avenues for biomedical research. In this round of awards, NCRR is supporting the purchase of two nuclear magnetic resonance (NMR) spectrometers, which are designed to view 3-D protein structures and complexes. For example, the University of Wisconsin - Madison will purchase a unique integrated liquid chromatography, mass spectrometry, and NMR system, currently unmatched at any other academic facility in the United States. This system combines three different technologies into a single powerful analytical platform useful in metabolic profiling, biomarker discovery, and studies of natural products and molecular interactions.

In addition, two high-powered electron microscopes, such as the one to Florida State University (FSU), will be supported through these awards. With its award, FSU will purchase a top-of-the-line, robotic electron microscope capable of rapid 3-D imaging of frozen specimens, enabling researchers to see the intricate interactive mechanisms of individual proteins and molecular machines within living cells. Capable of remote operation 24 hours a day, this critical research resource will provide scientists in the Southeast with an important tool to facilitate research in heart disease, hypertension, cancer, and HIV/AIDS.

Also, four more awards will support biomedical imagers that allow for noninvasive imaging at the molecular level. Researchers at the University of Pittsburgh, for example, will benefit from the latest hybrid imaging technology - a new system that combines positron emission tomography (PET) with magnetic resonance imaging (MRI) into one hybrid system. Immediately benefitting 11 NIH-funded research projects as a shared resource, this new technology offers physicians and radiologists new ways to investigate the progression of certain types of brain cancers and a variety of neurological studies, providing insight into Alzheimer's and Parkinson's diseases. Another award will support the University of Minnesota in its purchase of an MRI and magnetic resonance spectroscopy scanner equipped with an ultra-high magnetic field for in vivo studies of animal models. The first of its kind in the nation, this innovative imaging system will offer improved sensitivity and resolution, providing scientists a critical resource to better understand a variety of brain diseases.

Other HEI awards provide for the purchase of four high-resolution mass spectrometers that allow access to the newest analytical techniques to advance the knowledge of human diseases; two supercomputers that rapidly process vast quantities of data; two cyclotrons for producing new probes for noninvasive imaging at the molecular level; and many other types of specialized equipment.

To qualify for a HEI award, institutions must identify three or more NIH-funded investigators whose research requires the requested instrument. These grants provide a maximum of $2 million each. Institutions are expected to provide an appropriate level of support for associated infrastructure, such as building alterations or renovations, technical personnel, and post-award service contracts for instrument maintenance and operation.


Contact: Joyce McDonald
NIH/National Center for Research Resources

Related biology news :

1. The American Society of Plant Biologists announces 2007 awards
2. Singapore National Science and Technology Awards
3. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
4. NIH awards nearly $23M to University of Chicago for translational research
5. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
6. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
7. NIH awards UC $9 million grant to improve patient point-of-care technologies
8. NIST announces 56 new awards for innovative technology research and development
9. USP awards verified mark to Dr. Reddys Laboratories, Ltd. ingredients
10. Simons Foundation awards Emory scientists $3M for autism gene research
11. NIH grants $33 M in institutional development awards to 3 states
Post Your Comments:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
Breaking Biology Technology: